Weleda Infludoron® Globules

If Infludoron® Globuli are taken at the first signs of a cold, they can often prevent or mitigate the full course of the illness. Iron phosphate (Ferrum phosphoricum) supports natural defense mechanisms, reduces inflammatory symptoms, and regulates body temperature without blocking fever. Aconite has a calming effect on high fever and relieves pain. Eucalyptus promotes better breathing. Bryony and Water Hemp help regulate excessive mucus production and provide relief for body aches and a general feeling of malaise. Infludoron® Globuli contain no alcohol and are particularly suitable for sensitive individuals, children, pregnant women, infants, and nursing mothers.
 
Application note for infants: Dissolve globuli in a little tea.

Flu-like infections and febrile common colds.
 

Pregnancy and Breastfeeding
If you are pregnant, breastfeeding, believe you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
 
There are no indications of specific risks when used during pregnancy and breastfeeding. Nevertheless, caution is advised.

Adults and adolescents aged 12 years and over: 15 globuli every 1–2 hours; Children aged 6–11 years: 8–10 globuli every 1–2 hours; Children aged 1–5 years: 5–10 globuli 3–4 times daily; Children in the first year of life: 3–5 globuli 3–4 times daily. Let the globuli dissolve in your mouth. For children, they can also be dissolved in a little tea. Febrile illnesses in children under 1 year should always be medically supervised.

10 g of scatter globules contain:
The active ingredients include: 0.01 g Aconitum napellus D1; 0.06 g Bryonia D1; 0.05 g Eucalyptus globulus Ø (=D1); 0.04 g Eupatorium perfoliatum D1; 0.1 g Ferrum phosphoricum D6; 0.01 g Schoenocaulon officinale (Sabadilla) Ø (=D1).
 
The other ingredients are: Sucrose, Lactose monohydrate (in trace amounts).

For information on effects and possible side effects, please consult the package leaflet, your doctor or pharmacist.

Information as of 09/2025